ÂÜÀòÂÒÂ×

Christopher J. Schaber, PhD, currently serves as Chairman, President, and Chief Executive Officer of SOLIGENIX, INC. since August 2006. In addition to this role, Christopher J. Schaber is an Advisory Board Member at Simphotek since June 2018 and a Leadership Council Member of the National Small Business Association from February 2024. Christopher J. Schaber has been a Corporate Council Member of the National Organization for Rare Disorders since June 2011 and serves as a Board Member and Past Board Chair for BioNJ since February 2008. Furthermore, Christopher J. Schaber has been an investor, entrepreneur, and advisor since January 2005.